Stay updated on SNDX-5613 with Chemo in AML Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.

Latest updates to the SNDX-5613 with Chemo in AML Clinical Trial page
- CheckyesterdayChange DetectedFooter and header updates show Revision: v3.3.3, and the HHS Vulnerability Disclosure link was removed (as well as the previous Revision: v3.3.2 entry). This is a minor site-wide change that does not affect the study record content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedNew history entries were added for 2025-11-18, 2025-11-20, and 2025-11-21 with Revision: v3.3.2. The older Revision: v3.2.0 entry was removed.SummaryDifference0.6%

- Check37 days agoChange DetectedA banner about government funding status and NIH operating status was removed from the site header across the page.SummaryDifference0.4%

- Check51 days agoChange DetectedThe new screenshot shows the same record history structure and entries as the old one, with no additions or deletions; minor visual/UI alignment differences are present but do not affect content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedPage now includes an updated government-operating-status notice, a new current date, new study status entries with recent dates, and a version bump to v3.2.0; older date and version have been removed.SummaryDifference12%

- Check87 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.2%

Stay in the know with updates to SNDX-5613 with Chemo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.